Cibc Asset Management Inc Bio Rad Laboratories, Inc. Transaction History

Cibc Asset Management Inc

  • $28 Billion
  • Q4 2024

A detailed history of Cibc Asset Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 713 shares of BIO stock, worth $173,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares
713
Previous 679 5.01%
Holding current value
$173,658
Previous $227,000 3.08%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$313.15 - $374.28 $10,647 - $12,725
34 Added 5.01%
713 $234,000
Q3 2024

Nov 06, 2024
SELL
$263.97 - $344.64 $537,706 - $702,031
-2,037 Reduced 75.0%
679 $227,000
Q2 2024

Aug 01, 2024
SELL
$268.26 - $339.48 $61,968 - $78,419
-231 Reduced 7.84%
2,716 $741,000
Q1 2024

May 09, 2024
BUY
$304.11 - $351.99 $23,416 - $27,103
77 Added 2.68%
2,947 $1.02 Million
Q4 2023

Feb 13, 2024
SELL
$269.37 - $365.04 $26,667 - $36,138
-99 Reduced 3.33%
2,870 $926,000
Q3 2023

Oct 30, 2023
SELL
$350.25 - $422.63 $21,015 - $25,357
-60 Reduced 1.98%
2,969 $1.06 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $12,222 - $16,537
-34 Reduced 1.11%
3,029 $1.15 Million
Q1 2023

May 12, 2023
SELL
$418.69 - $503.0 $22,190 - $26,659
-53 Reduced 1.7%
3,063 $1.47 Million
Q4 2022

Feb 13, 2023
SELL
$351.71 - $456.01 $4,572 - $5,928
-13 Reduced 0.42%
3,116 $1.31 Million
Q3 2022

Nov 03, 2022
BUY
$412.59 - $563.26 $70,965 - $96,880
172 Added 5.82%
3,129 $1.31 Million
Q2 2022

Aug 09, 2022
SELL
$463.67 - $597.16 $1.05 Million - $1.35 Million
-2,263 Reduced 43.35%
2,957 $1.46 Million
Q1 2022

May 06, 2022
SELL
$524.57 - $735.42 $578,600 - $811,168
-1,103 Reduced 17.44%
5,220 $2.94 Million
Q4 2021

Feb 08, 2022
BUY
$708.84 - $794.68 $57,416 - $64,369
81 Added 1.3%
6,323 $4.78 Million
Q3 2021

Nov 09, 2021
BUY
$657.71 - $825.77 $164,427 - $206,442
250 Added 4.17%
6,242 $4.66 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $302,159 - $340,096
524 Added 9.58%
5,992 $3.86 Million
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $183,795 - $222,549
336 Added 6.55%
5,468 $3.12 Million
Q4 2020

Feb 03, 2021
BUY
$510.68 - $643.45 $112,860 - $142,202
221 Added 4.5%
5,132 $2.99 Million
Q3 2020

Nov 05, 2020
BUY
$454.43 - $535.6 $1.26 Million - $1.49 Million
2,780 Added 130.46%
4,911 $2.53 Million
Q2 2020

Jul 28, 2020
BUY
$334.87 - $493.06 $347,929 - $512,289
1,039 Added 95.15%
2,131 $962,000
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $3,517 - $4,116
11 Added 1.02%
1,092 $404,000
Q2 2018

Aug 09, 2018
BUY
$244.1 - $303.88 $8,543 - $10,635
35 Added 3.35%
1,081 $312,000
Q3 2017

Nov 06, 2017
BUY
$212.27 - $242.28 $222,034 - $253,424
1,046
1,046 $232,000

Others Institutions Holding BIO

# of Institutions
477
Shares Held
18.3M
Call Options Held
15.7K
Put Options Held
11.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email